Cargando…

Development and Preliminary Validation of an Instrument to Measure Symptoms and Impacts in Patients with Proliferative Diabetic Retinopathy

INTRODUCTION: Following a review of patient-reported outcome (PRO) instruments in the literature, existing PRO instruments may not adequately capture the experience of receiving treatment for proliferative diabetic retinopathy (PDR). Therefore, this study aimed to develop a de novo instrument to com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rofail, Diana, Sherman, Steven, Hartford, Christopher, Levine, Adele, Baldasaro, Jessica, Marquis, Patrick, Rao, Rohini, Do, Diana V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969934/ https://www.ncbi.nlm.nih.gov/pubmed/36848017 http://dx.doi.org/10.1007/s12325-023-02447-8

Ejemplares similares

The Patient Experience with Diabetic Retinopathy: Qualitative Analysis of Patients with Proliferative Diabetic Retinopathy
por: Sherman, Steven A., et al.
Publicado: (2022)

“I Can’t Take off My Shirt or Do My Own Hair”—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP)
por: Markowitz, Jessica T., et al.
Publicado: (2022)

Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity
por: Hartford, Christopher A., et al.
Publicado: (2023)

Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients
por: Rofail, Diana, et al.
Publicado: (2022)

PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
por: Hartford, Christopher, et al.
Publicado: (2023)

Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
por: Nguyen, Quan Dong, et al.
Publicado: (2023)

Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy
por: Guo, Yian, et al.
Publicado: (2023)

Patient experience of symptoms and impacts of COVID-19: a qualitative investigation with symptomatic outpatients
por: Rofail, Diana, et al.
Publicado: (2022)

Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities — preliminary data for PPPM validation
por: Kropp, Martina, et al.
Publicado: (2023)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Proliferative diabetic retinopathy in acromegaly
por: Malhotra, Chintan
Publicado: (2010)

Novel therapies for proliferative retinopathies
por: Martinez-Alejo, Juan Manuel, et al.
Publicado: (2022)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Growth Factors in Proliferative Diabetic Retinopathy
por: Khan, Zia Ali, et al.
Publicado: (2003)

Candidate Genes for Proliferative Diabetic Retinopathy
por: Petrovič, Daniel
Publicado: (2013)

Predicting Development of Proliferative Diabetic Retinopathy
por: Harris Nwanyanwu, Kristen, et al.
Publicado: (2013)

The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy
por: Zhu, Xuemei, et al.
Publicado: (2015)

Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023)

Measuring the Patient Experience in Rare Disorders: Benefit of Pragmatic Mixed-Methods Research in NUT Carcinoma
por: Ciesluk, Anna, et al.
Publicado: (2022)

Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
por: Do, Diana V., et al.
Publicado: (2022)

Assessing the impact on caregivers of patients with schizophrenia: psychometric validation of the Schizophrenia Caregiver Questionnaire (SCQ)
por: Rofail, Diana, et al.
Publicado: (2016)

Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
por: Loporchio, Dean F., et al.
Publicado: (2021)

Homocysteine Serum Levels in Diabetic Patients with Non Proliferative, Proliferative and without Retinopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2014)

Automated detection of proliferative retinopathy in clinical practice
por: Karperien, Audrey, et al.
Publicado: (2008)

Characterisation of the vitreous proteome in proliferative diabetic retinopathy
por: Wang, Hao, et al.
Publicado: (2012)

Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Choroidal Osteoma Accompanied by Proliferative Diabetic Retinopathy
por: Choi, Hyun Sup, et al.
Publicado: (2018)

Pupillary responses in non-proliferative diabetic retinopathy
por: Park, Jason C., et al.
Publicado: (2017)

Plasma metabolomic profiling of proliferative diabetic retinopathy
por: Zhu, Xiao-Rong, et al.
Publicado: (2019)

Wide-field imaging in proliferative diabetic retinopathy
por: Liu, T. Y. Alvin, et al.
Publicado: (2019)

Hypertension: A Cause of Bilateral Proliferative Retinopathy
por: Jung, Eric E., et al.
Publicado: (2023)

Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's Disease
por: Mcgrath, Clare, et al.
Publicado: (2010)

Development and content validation of the Symptoms Evolution of COVID-19: a patient-reported electronic daily diary in clinical and real-world studies
por: Rofail, Diana, et al.
Publicado: (2022)

Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
por: Perais, Jennifer, et al.
Publicado: (2023)

The Association of Neovascularization With Optical Coherence Tomography Angiography Parameters in Proliferative Diabetic Retinopathy
por: Sodhi, Punita K, et al.
Publicado: (2023)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy
por: Lu, Qiang, et al.
Publicado: (2014)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
por: Shi, Lei, et al.
Publicado: (2012)

Surgery for Proliferative Diabetic Retinopathy: New Tips and Tricks
por: Oellers, Patrick, et al.
Publicado: (2016)

Vitrectomy for Proliferative Diabetic Retinopathy Associated with Klinefelter Syndrome
por: Tajiri, Kensuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4d6usse068q95vk8nol3vrb3eu